wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47139649-3A1EAD42-652E-4625-B316-15E69F806F0A
Q47139649-3A1EAD42-652E-4625-B316-15E69F806F0A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47139649-3A1EAD42-652E-4625-B316-15E69F806F0A
Characterization of the efficacies of osimertinib and nazartinib against cells expressing clinically relevant epidermal growth factor receptor mutations.
P2860
Q47139649-3A1EAD42-652E-4625-B316-15E69F806F0A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47139649-3A1EAD42-652E-4625-B316-15E69F806F0A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d38d11e1401e0c509e4abb70e67778f7e83b2ad7
P2860
EGFR-independent mechanisms of acquired resistance to AZD9291 in EGFR T790M-positive NSCLC patients.